Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Oct 2026 for Arcutis Biotherapeutics, Inc., €114k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Howard Welgus: trading record in brief
Howard Welgus discloses dealings in Arcutis Biotherapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 June 2026 to 15 October 2026, the count stands at 6 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 15 October 2026: a transaction of €114k, in Arcutis Biotherapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Howard Welgus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,728 shares@ US$26.93CommonSEC144:0001628280-26-065989
4,730 shares@ US$24.180.0034% mcap23.7% of flowCommonSEC144:0001628280-26-062042
4,730 shares@ US$26.18070.0037% mcap25.6% of flowCommonSEC144:0001628280-26-057390
4,730 shares@ US$26.910.0038% mcap26.6% of flowCommonSEC144:0001628280-26-048326
635 shares@ US$25.670.0004% mcap3.4% of flowCommonSEC144:0001628280-26-043877
4,096 shares@ US$24.40930.0027% mcap20.6% of flowCommonSEC144:0001628280-26-043178
6 of 6 declarations
